Téllez-Navarrete Norma A, Romero-Tendilla Jesús, Morales Alejandra, Becerril Eduardo, Alvarado-Peña Néstor, Salazar-Lezama Miguel A, Garciadiego-Fossas Pamela, Cadena-Torres Eliane, Chavez-Galan Leslie, Ramón-Luing Lucero A
Department of Healthcare Coordination, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Mexico City, Mexico.
Laboratory of Integrative Immunology, Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas", Mexico City, Mexico.
Front Public Health. 2025 Mar 21;13:1505914. doi: 10.3389/fpubh.2025.1505914. eCollection 2025.
During the COVID-19 pandemic outbreak in 2020 until 2023, healthcare resources dedicated to critical diseases, including respiratory conditions like Tuberculosis (TB), were significantly impacted worldwide. The Instituto Nacional de Enfermedades Respiratorias "Ismael Cosío Villegas" (INER), a leading tertiary-level hospital in Mexico City and a national reference center for respiratory diseases, was designated exclusively for COVID-19 patients during these years.
This report aims to assess the pandemic's impact on TB care at INER and propose strategies for improving TB management by integrating lessons learned from the pandemic. TB presumptive cases were reviewed between 2016-2023, covering pre-pandemic, pandemic, and post-period; the number of diagnosis tests performed and number of attending TB patients in the emergency areas, hospitalization, or outpatient consultation were analyzed. The mortality rate of patients during hospitalization was also examined.
Our analysis revealed that during the pre-pandemic period (2016-2019), around 1,000 TB patient consultations were managed annually across outpatient and inpatient settings, and it drastically declined in 2020, a trend that persisted through 2021 and 2022. Survival of TB patients was affected, and disruption in TB care resulted in a decrease in TB diagnoses during the pandemic and increased mortality rates among hospitalized patients during the post-pandemic period. In response to the challenges posed by the pandemic, INER adopted innovative strategies such as telehealth services and reinforced human resources dedicated to respiratory pathologies. These efforts and enhanced diagnostic testing have strengthened the hospital's capacity to care for TB patients. The lessons learned during the pandemic have been pivotal in reshaping and improving the healthcare system's approach to managing TB in a tertiary care setting.
在2020年至2023年新冠疫情爆发期间,全球范围内用于治疗包括结核病(TB)等严重疾病的医疗资源受到了重大影响。墨西哥城的一家领先的三级医院——国家呼吸疾病研究所“伊斯梅尔·科西奥·比列加斯”(INER),也是全国呼吸疾病参考中心,在这些年里专门收治新冠患者。
本报告旨在评估疫情对INER结核病护理的影响,并通过整合从疫情中吸取的经验教训,提出改善结核病管理的策略。回顾了2016 - 2023年间结核病疑似病例,涵盖疫情前、疫情期间和疫情后时期;分析了所进行的诊断测试数量以及急诊区、住院部或门诊咨询中结核病患者的就诊人数。还检查了患者住院期间的死亡率。
我们的分析显示,在疫情前时期(2016 - 2019年),门诊和住院环境中每年约有1000例结核病患者咨询,2020年急剧下降,这一趋势在2021年和2022年持续存在。结核病患者的生存受到影响,疫情期间结核病护理的中断导致结核病诊断减少,疫情后住院患者死亡率增加。为应对疫情带来的挑战,INER采取了远程医疗服务等创新策略,并加强了专门从事呼吸道疾病治疗的人力资源。这些努力以及强化的诊断测试增强了医院护理结核病患者的能力。疫情期间吸取的经验教训对于重塑和改善三级医疗环境中医疗系统管理结核病的方法起到了关键作用。